SERPINH1 and hepatocellular carcinoma: Among them, SERPINH1 (HSP47), as a molecular chaperone involved in collagen folding 35, is the only one that could stably identify high-risk recurrent patients in both tumors and NATs of all HCC cohorts and has corresponding targeted drugs, making it a potential high-performance recurrence prediction marker and drug target (Figure 3D).